SCHEMBL10694441

SCHEMBL10694441

FC(F)(F)c1ccc2nc(C(F)(F)F)[nH]c2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.65
ALDH1A1 P00352 2/20 0.65
HPGD P15428 2/20 0.65
MAPT P10636 2/20 0.65
CYP1A2 P05177 1/20 0.65
CYP2C9 P11712 1/20 0.65
ALOX15 P16050 1/20 0.65
CYP2C19 P33261 1/20 0.65
HSD17B10 Q99714 1/20 0.65
NPBWR1 P48145 6/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
KCNH2 Q12809 5/20 0.56
DGAT1 O75907 4/20 0.56
SCN10A Q9Y5Y9 2/20 0.54
DYRK1A Q13627 1/20 0.54
DYRK1B Q9Y463 1/20 0.54
LMNA P02545 1/20 0.54
HTT P42858 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14336639 0.88 KCNH2 (0.62) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL3885700 0.88 NPBWR1 (0.55) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL5681855 0.85 NPSR1 (0.59) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL6090961 0.81 KDM4E (0.52) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL30016904 0.80 ALDH1A1 (0.63) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL1887466 0.80 ALDH1A1 (0.63) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL30672494 0.80 NPBWR1 (0.58) KDM4EMAPTNPBWR1KCNH2DGAT1
SCHEMBL521212 0.80 MAPT (0.97) KDM4EALDH1A1HPGDMAPTCYP1A2
SCHEMBL21500616 0.80 NPBWR1 (0.58) MAPTHSD17B10NPBWR1KCNH2DGAT1
SCHEMBL16042060 0.80 ALDH1A1 (0.63) KDM4EALDH1A1HPGDMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734677-B2 Substituted imidazole and benzimidazole lithium salts ROBERT BOSCH GMBH (DE) 2020-08-04 US disclosed
WO-2019005216-A1 SUBSTITUTED IMIDAZOLE AND BENZIMIDAZOLE LITHIUM SALTS SEEO, INC. (US) 2019-01-03 WO disclosed
CN-105237480-B A kind of 2 trifluoro methyl benzimidazole compounds and preparation method thereof 三峡大学 2017-12-05 CN disclosed
EP-0251012-A2 N-sulfenyl-2-trifluoromethyl benzimidazoles BAYER AG (DE) 1988-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10734677-B2 Substituted imidazole and benzimidazole lithium salts KCNJ11, KCNJ1, KCNJ8 KDM4E 676/4885ALDH1A1 1039/4885HPGD 2817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.